The FDA reports that Philips Trilogy ventilators reworked as a part of the June 2021 recall have two new potential issues that may affect performance and safety.
Tag: ventilation noninvasive
Respiratory failure due to hypoxemia and/or hypercapnia calls for oxygen therapy, positive pressure support, and possibly ventilatory support. Care for these patients may escalate and require higher flow, FiO2, and more complex devices and intensive monitoring.Read More
A low-cost, easy-to-build noninvasive ventilator that cost about $75 performed similarly to conventional commercial devices, according to ERJ research.Read More
Researchers studying late failure of noninvasive ventilation in hospitalized patients suffering COPD exacerbations found that certain risk factors were tied to NIV failure, but that transitioning these patients that fail NIV to invasive ventilation could reduce mortality.Read More
The Philips BiPAP A40 EFL is the first and only noninvasive ventilator that automatically screens for and detects EFL and provides home care ventilation for COPD patients.Read More
RT Magazine’s free webinar on noninvasive ventilation (NIV) therapy for COVID-19 patients is now available on-demand.Read More
The move comes in response to the novel COVID-19 pandemic, the President’s exercise of the Defense Production Act, public concern regarding access to ventilators, and the NIV product category being new to the DMEPOS Competitive Bidding Program.Read More